Company Profarm Srl with Fiscal Code 17539418
recorded a turnover of 2024 of
47.832,
with a net profit of
12.544
and having an average number of employees of
3.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Profarm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
259.652
229.925
233.629
251.082
216.362
277.947
255.948
281.019
281.952
47.832
Total Income - EUR
259.705
232.001
239.749
299.556
218.831
332.241
284.923
288.030
296.985
101.200
Total Expenses - EUR
269.421
215.840
231.011
284.761
239.459
364.071
281.494
274.326
286.732
87.058
Gross Profit/Loss - EUR
-9.716
16.161
8.738
14.796
-20.628
-31.830
3.429
13.704
10.253
14.142
Net Profit/Loss - EUR
-9.716
13.536
4.855
11.735
-22.825
-35.135
1.367
10.855
7.639
12.544
Employees
4
5
6
7
7
5
5
3
3
3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -82.9%, from 281.952 euro in the year 2023, to 47.832 euro in 2024.
The Net Profit increased by 4.948 euro, from 7.639 euro in 2023, to 12.544 in the last year.
Check the financial reports for the company - Profarm Srl
Financial Rating - PROFARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Profarm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Profarm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Profarm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
40.951 euro in 2024 which includes Inventories of
18.440 euro, Receivables of
18.284 euro and cash availability of
4.227 euro.
The company's Equity was valued at
26.517 euro, while total Liabilities amounted to
51.841 euro.
Equity increased by 12.544 euro, from 14.052 euro in 2023, to 26.517 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Profarm Srl